GENE ONLINE|News &
Opinion
Blog

Migraine
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Pfizer Trumpets Lancet Publication Of Migraine Drug’s Phase 3 Results
2023-02-18
Pfizer Buys Biohaven For $11.6 Billion, Bags Migraine Asset
2022-05-11
Amgen Announces Encouraging Full Data for Migraine Drug, Aimovig
2021-11-09
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
Spotlight: The Revitalization of Chronic Migraine Therapies
2020-09-02
Ubrelvy Approval, the Best New Year Gift for CGRP Migraine Victims
2020-01-09
Weekly Top 5 in China (0210-0216)
2019-02-18
Clash of three migraines medications & cost benefit for patients
2018-10-01
AJOVY™, Teva’s new migraine drug gets USFDA approval
2018-09-21
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top